As early as 10 weeks
Luminus’ tests require a single blood draw. It can be done as early as 10 weeks or later in pregnancy.
Other commonly used tests for Down syndrome are performed later in pregnancy and may require multiple office visits.
Luminus’ tests are validated for pregnant women of any age or risk categories and trusted by clinicians worldwide. AS EARLY AS 10 WEEKS, Luminus’ tests screen for the risk of trisome 21, 18, and 13.
Luminus’ tests have a less than 0.1% false-positive rate for trisomies 21, 18, and 13
This means fewer than 1 in 1000 Luminus’ tests yields a false-positive result. With conventional screening, as many as 1 in 20 women will receive a false-positive result 4
Luminus’ tests have exceptional accuracy, bringing clarity to genetic testing for common trisomies.
In blinded clinical trials, tests correctly identified over 99% of cases of trisome 211-2
Conventional screening tests can miss 15% or more of trisome 21 cases4
Luminus’ tests help healthcare professionals give expectant parents accurate information about common fetal aneuploidies. 1-4 Conventional prenatal screening methods using serum proteins and ultrasound have higher false-positive rates compared to the Luminus’ tests.1-4 The low false-positive rate of Luminus compared to traditional tests may minimize anxiety and invasive procedures caused by false-positive results.5-6
Luminus’ tests are clinically validated for use in pregnant women, of any age or risk category, to assess the risk of fetal trisomies 21, 18 and 13.1-3
Studied extensively in blinded prospective trials including more than 22,000 women of all ages1-2,8-9,11
Over 500,000 pregnancies tested worldwide13
Luminus uses a targeted technological approach to DNA assessment—focusing on analyzing only the specific chromosomes of interest and the precise measurement of fetal DNA using SNPs (single nucleotide polymorphisms) to achieve greater accuracy.7
When you are pregnant, your blood contains fragments of your baby’s DNA.
Luminus’ tests are a new type of tests that analyze DNA in a sample of your blood to predict the risk of Down syndrome (trisome 21) and certain other genetic conditions.
Luminus’ tests require a single blood draw. It can be done as early as 10 weeks or later in pregnancy.
Other commonly used tests for Down syndrome are performed later in pregnancy and may require multiple office visits.
The Luminus’ tests are screening tests that are more accurate than traditional Down syndrome blood tests.1 The tests are much less likely to give a false-positive result compared to traditional tests such as the first trimester screening test. That means there will be much less chance your doctor would recommend follow-up diagnostic testing, such as amniocentesis.
Luminus also tests for two other genetic conditions, trisome 18 (Edward syndrome) and trisome 13 (Patau syndrome).
In addition, with Luminus you have the option to evaluate fetal sex, X and Y sex chromosomes.
Non-invasive prenatal testing based on cell-free DNA analysis is not considered diagnostic. Once you have your Luminus test results, you can discuss your pregnancy care with your healthcare provider.
| False Positive Rate* | Detection Rate** | |
| Harmony Prenatal Test | Less than 1 in 1,600 | More than 99 in 100 |
| Traditional Test*** | 1 in 20 | 79 in 100 |
†Both under 35 and over 35 age groups, studies have included women ages 18-48
* This test is designed to assess risk for trisome 21, 18, and 13 and sex chromosome aneuploidy. It cannot exclude all genetic defects nor detect every problem that may occur in pregnancy.
| Monday | 9:00AM - 5:00PM |
| Tuesday | 9:00AM - 5:00PM |
| Wednesday | 9:00AM - 5:00PM |
| Thursday | 9:00AM - 5:00PM |
| Friday | 9:00AM - 5:00PM |
| Saturday | CLOSED |
| Sunday | CLOSED |
477 Madison Avenue,
6th floor,
New York, NY 10022
Email. support@standardmed.us
10752 Deerwood Park Blvd.,
Suite 100,
Jacksonville, FL 32256
Email. support@standardmed.us
1700 Rockville Pike,
Suite #400, 4th Floor,
Rockville, MD 20852
Email. support@standardmed.us
Standard Medical Equipment Systems, LLC – DBA, (“Standard Med” ) is a certified minority (MBE) Veteran (SDVOSB) owned company, certified by the Center for Veteran Enterprises, (CVE). Standard Med was established by Anthony B. Goodesmith, in the year 2005, to deliver high quality medical devices and laboratory equipment. Mr. Goodesmith served as a highly decorated combat signaler/communications officer in the U.S. Army and New Jersey National Guard for over 18 years. His units took part in Operation Desert Storm, and several other military campaigns after the 9/11 U.S. Terror Attacks (Operations Enduring Freedom and Noble Eagle). He received his B.S. in Marketing and Media Arts from Long Island University, NY, and his Master’s degree in Biotechnology Management from The University of Maryland University College (UMUC).Mr. Goodesmith has been working in the health care, medical industry in sales and management for over 20 years at several Fortune 500 pharmaceutical and medical device companies. Such as Eli Lilly & Company, Solvay Pharmaceuticals, AstraZeneca, Inc., Roche Laboratories, Inc. and now Standard Medical Systems, LLC. He has received the Elite Salesman Award, President’s Award, U.S. Congressional VIP Citation, and achieved #1 status in selling various pharmaceutical drugs and medical devices throughout his career. Mr. Goodesmith shares his tremendous expertise as a staff writer for the DC Health-Technology Examiner, based on his exceptional knowledge about the epidemiology of health-related issues and via medical device, regenerative, biological solutions. You may reach Mr. Goodesmith at his corporate email address: tony@standardmed.us. We pride ourselves on our distinct array of medical devices and diagnostic equipment we offer to the healthcare community, which delivers the highest quality control, safety and efficacy with the latest breakthroughs in medical technology.
Our ultimate aim is to work daily with the sole purpose of raising the standards of healthcare delivery for all people.
We are part of the health care technology industry. Our target market is the US Federal Government, VAMC’s, DOD, State and local municipal agencies, and the overall wholesale/retail healthcare consumer market. Our primary products are diagnostic medical devices, to include durable medical equipment, regenerative medicine, and surgical implants/ wound care products. Important characteristics of these products are to aid in the diagnosis and to facilitate treatment of particular disease states and physical ailments of various types. Our products differ from our competitors, in that we offer state of the art cutting edge medical devices, diagnostics and supplies in an underserved and specialized market population.
1700 Rockville Pike,
Suite #400, 4th Floor,
Rockville, MD 20852
Email. support@standardmed.us
477 Madison Avenue,
6th floor,
New York, NY 10022
Email. support@standardmed.us
10752 Deerwood Park Blvd.,
Suite 100,
Jacksonville, FL 32256
Email. support@standardmed.us
